⌘K

Mass General Brigham Ventures logo

Mass General Brigham Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

3

Common Fundraising Type

Series B

Abcuro logo
Abcuro

Biotechnology • Clinical-stage

New Enterprise Associates logo
Soleus Capital logo
Sanofi Ventures logo
RA Capital Management logo

Abcuro, Inc. is a biotechnology company developing therapies for autoimmune diseases and cancer, with a focus on their lead candidate, ulviprubart, a monoclonal antibody for treating inclusion body myositis.

Series C
$200M
02/12/2025
Article
Rippl logo
Rippl

Virtual dementia care • AI technology

Kin Ventures logo
Mass General Brigham Ventures logo
JSL Health logo
GV logo

Rippl is a virtual dementia care company focused on providing tech-driven care solutions and expanding its network of healthcare providers for senior-focused behavioral health.

Series A
$23M
10/09/2024
Article
ROME Therapeutics logo
ROME Therapeutics

Biotechnology • Autoimmune Diseases

Section 32 logo
Sanofi Ventures logo
Raycap logo
Mirae Asset Capital logo

ROME Therapeutics is a biotechnology company that develops breakthrough medicines for serious diseases, with a focus on an inhibitor of LINE-1 reverse transcriptase for autoimmune diseases, using their proprietary data science platform to identify active repeat elements and assess their roles in disease.

Series B
$72M
09/12/2023
Article